Understanding velocardiofacial syndrome: how recent discoveries can help you improve your patient outcomes.

@article{Chinnadurai2012UnderstandingVS,
  title={Understanding velocardiofacial syndrome: how recent discoveries can help you improve your patient outcomes.},
  author={Sivakumar Chinnadurai and Steven L. Goudy},
  journal={Current opinion in otolaryngology & head and neck surgery},
  year={2012},
  volume={20 6},
  pages={502-6}
}
PURPOSE OF REVIEW Improved recognition of velocardiofacial syndrome (VCFS) has led to increasing awareness of VCFS by otolaryngologists. Understanding the developmental biologic processes affected in VCFS patients will help improve treatment and outcomes. Advanced application of molecular labeling techniques has better outlined the role of T-Box transcription factor 1 (TBX1) as the primary genetic anomaly leading to VCFS. TBX1 plays multiple roles during branchial, cardiac, and craniofacial… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 23 references

Cortical gyrification in velocardiofacial ( 22 q 11 . 2 deletion ) syndrome : a longitudinal study

  • A Kunwar, S Ramanathan, J Nelson
  • Schizophr Res
  • 2012

Identification of a Tbx 1 / Tbx 2 / Tbx 3 genetic pathway governing pharyngeal and arterial pole morphogenesis

  • K Mesbah, MS Rana, A Francou
  • Hum Mol Genet
  • 2012

Immunological aspects of 22 q 11 . 2 deletion syndrome

  • AR Gennery
  • Cell Mol Life Sci : CMLS
  • 2012

Similar Papers

Loading similar papers…